Company Directory > CRO > Novagenix Bioanalytical Drug R&D Center
Novagenix is a leading Contract Research Organization (CRO) based in Ankara, Turkey, specializing in bioavailability and bioequivalence (BA/BE) studies. The company provides comprehensive R&D services to the pharmaceutical and biotechnology industries, including generic drug development, formulation development, analytical method development, and clinical trial support. Operating in strict compliance with international standards such as GLP (Good Laboratory Practices), GCP (Good Clinical Practice), and ISO certifications, Novagenix serves as a key partner for both national and international pharmaceutical sponsors. Their facilities are equipped for advanced analytical testing and clinical trial management, aiming to facilitate the licensing and market access of pharmaceutical products.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:-
Industry:CRO
Sub-Industry:Bioavailability/Bioequivalence Studies
SIZE & FINANCIALS
Employees:51-200
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Erciyes University Faculty of Medicine (Hakan Çetinsaya GCP Center), Gaziantep University Faculty of Medicine (FARMAGEN Clinical Research Center)
COMPETITION
Position:Niche Player
Competitors:Other regional and international CROs specializing in bioequivalence
LEADERSHIP
Key Executives:
Onursal Saglam - General Manager
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Novagenix Bioanalytical Drug R&D Center and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Novagenix Bioanalytical Drug R&D Center. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.